文献速递眼底病与葡萄膜炎

爱尔兰人群中年龄相关性黄斑变性相关遗传风险因素的患病率及4年进展数据

Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population.
PubMed 文献 · Br J Ophthalmol · 2018-02-16

在爱尔兰老龄化纵向研究(TILDA)4473名≥50岁参与者中,评估年龄相关性黄斑变性(AMD)相关遗传风险变异(CFH rs1061170、ARMS2 rs10490924、C3 rs2230199、CFB rs641153、SKIV2L rs429608)的患病率及4年进展率。高龄及携带CFH和ARMS2风险等位基因是与AMD患病相关的主要风险因素,23%的AMD病例进展至更高级别。CFH风险等位基因携带者与疾病进展强相关,ARMS2风险等位基因杂合性可预测进展为晚期AMD。

要点

  • 高龄及携带CFH和ARMS2风险等位基因是与AMD患病相关的主要风险因素。
  • 23%的AMD病例在4年内进展至更高级别,CFH风险等位基因携带者与疾病进展强相关。
  • ARMS2风险等位基因杂合性可预测进展为晚期AMD,75%从早期进展至晚期者基线有软性玻璃膜疣和色素沉着。

核心结论

  • 该爱尔兰队列中AMD相关风险基因的患病率和4年进展率与其他高加索人群相当。
  • CFH Y402H与疾病进展相关,软性玻璃膜疣和色素沉着为高风险特征。

研究设计与样本

  • 基于人群代表性队列(爱尔兰老龄化纵向研究TILDA)的遗传关联及4年随访研究。
  • 共评估4473名≥50岁参与者,其中4173名无AMD(男性1843名,44%;女性2330名,56%;平均年龄60±9.0岁),300名患AMD(男性136名,45%;女性164名,55%;平均年龄64±9.0岁)。
  • 对AMD病例进行4年随访,66%的AMD病例参加随访。
  • 评估早期至晚期AMD的进展和消退,采用多项逻辑回归评估遗传关联作为疾病指标和进展预测因素。

主要发现

  • 高龄及携带CFH和ARMS2风险等位基因是与TILDA队列中AMD患病相关的主要风险因素。
  • 23%的AMD病例进展至更高级别。
  • CFH风险等位基因携带者与疾病进展强相关。
  • ARMS2风险等位基因杂合性可预测进展为晚期AMD。
  • 75%从早期进展至晚期疾病者基线有软性玻璃膜疣和色素沉着。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: Age-related macular degeneration (AMD) is estimated to affect 196 million people >50 years old globally. Prevalence of AMD-associated genetic risk factors and rate of disease progression are unknown in Ireland. METHODS: Prevalence of AMD-associated genetic risk variants, complement factor H (CFH) rs1061170, age-related maculopathy susceptibility 2 (ARMS2) rs10490924, component 3 (C3) rs2230199, complement factor B (CFB) rs641153 and superkiller viralicidic activity 2-like (SKIV2L) rs429608 and 4-year progression data in a population-representative cohort (The Irish Longitudinal study on Ageing (TILDA)) were assessed. 4473 participants ≥50 years were assessed. 4173 had no disease n=1843; 44% male and n=2330; 56% female, mean age 60±9.0, 300 had AMD n=136; 45% male and n=164; 55% female, mean age 64±9.0. A 4-year follow-up was undertaken with 66% of AMD cases attending. Progression and regression from early to late AMD were measured. Genetic association as indicators of disease and as predictors of progression were assessed by multinomial logistic regression. RESULTS: Older age and the presence of CFH and ARMS2 risk alleles are two main risk factors associated with the prevalence of AMD in the TILDA cohort. 23% progressed to a higher grade of AMD. Carriers of CFH risk allele showed a strong association for disease progression. Heterozygosity for ARMS2 risk allele predicted progression to late AMD. 75% of those who progressed from early to late disease had soft drusen and hyperpigmentation at baseline. CONCLUSIONS: The prevalence of risk-associated genes and 4-year progression rates of AMD in this Ireland cohort are comparable with other Caucasian populations. CFH Y402H is associated with disease progression, with soft drusen and hyperpigmentation as high-risk features.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Connolly E, Rhatigan M, O'Halloran AM, et al. Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population. Br J Ophthalmol. 2018. PMID: 29453225. doi:10.1136/bjophthalmol-2017-311673

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。